Suchergebnisse - "Singanayagam, Aran"

PubPharm (7)

1

Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma : a pilot randomised controlled trial

enthalten in: Thorax | 2022

von Farne, H. | Glanville, N. | Johnson, N. | +12

2

Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon

enthalten in: The Journal of allergy and clinical immunology | 2021

von Finney, L. | Glanville, N. | Farne, H. | +11

CommentIn: J Allergy Clin Immunol. 2021 Mar;147(3):1117. - PMID 33388167

3

Long-term impact of inhaled corticosteroid use in asthma and chronic obstructive pulmonary disease (COPD) : Review of mechanisms that underlie risks

enthalten in: The Journal of allergy and clinical immunology | 2020

von Singanayagam, A. | Johnston, S.

4

Treatment of COVID-19-exacerbated asthma : should systemic corticosteroids be used?

enthalten in: American journal of physiology. Lung cellular and molecular physiology | 2020

von Kumar, K. | Hinks, T. | Singanayagam, A.

5

Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease

enthalten in: Science translational medicine | 2019

von Singanayagam, A. | Glanville, N. | Cuthbertson, L. | +17

6

Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations

enthalten in: Nature communications | 2018

von Singanayagam, A. | Glanville, N. | Girkin, J. | +26

7

Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease

enthalten in: The Lancet. Respiratory medicine | 2014

von Finney, L. | Berry, M. | Singanayagam, A. | +3

1
[1]